A5057745244- Transplantation: Methods and Outcomes
- Pneumocystis jirovecii pneumonia detection and treatment
- Renal Transplantation Outcomes and Treatments
- Tuberculosis Research and Epidemiology
- Organ Transplantation Techniques and Outcomes
- Renal Diseases and Glomerulopathies
- Dialysis and Renal Disease Management
- Cytomegalovirus and herpesvirus research
- COVID-19 Clinical Research Studies
- Fungal Infections and Studies
- Neurological Complications and Syndromes
- Viral-associated cancers and disorders
- Antifungal resistance and susceptibility
- Metabolism and Genetic Disorders
- Hemoglobinopathies and Related Disorders
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Diagnosis and treatment of tuberculosis
- Hepatitis C virus research
- Chronic Kidney Disease and Diabetes
- Neurological and metabolic disorders
- Central Venous Catheters and Hemodialysis
- Polyomavirus and related diseases
- Blood groups and transfusion
- HIV/AIDS drug development and treatment
- Acute Kidney Injury Research
Max Super Speciality Hospital
2019-2024
Post Graduate Institute of Medical Education and Research
2016-2020
Max Healthcare
2019
<br><b>Introduction:</b> Fungi are ubiquitous organisms and significantly alter the post-transplant course. They a major cause of morbidity mortality more so in developing countries. <b>Aims:</b> To study clinical profile, etiology, risk factors, treatment, outcome fungal infections post-renal transplant recipients. <b>Materials Methods:</b> This was cross-sectional observational retrospective from January 2014 to June 2017 wherein renal recipients with invasive infection were included...
<br>Granulomatosis with polyangiitis (GPA) commonly affects upper/lower respiratory tract and kidneys. It causes necrotizing vasculitis of small medium-sized blood vessels. Gastrointestinal (GI) involvement is an uncommon manifestation GPA, presentation predominant GI noteworthy. We report a case 50-year-old male melena due to along other systemic involvement. The patient was treated pulse methylprednisolone, cyclophosphamide, plasmapheresis. To manage the refractory bleed, underwent...
Rifampicin is one of the most effective components anti-tuberculous therapy (ATT). Since rifampicin a hepatic enzyme (CYP3A4) inducer, in post-renal transplant recipient, dose calcineurin inhibitors needs to be up-regulated and frequently monitored. In resource-limited (low- lower-middle-income countries) setting this not always feasible. Therefore, we evaluated non-rifampicin-based ATT using levofloxacin kidney recipients.We retrospectively studied medical records renal recipients diagnosed...
Abstract Background Tuberculosis (TB) is a common infection in chronic kidney disease. The prolonged therapy of TB can delay transplantation patients on antitubercular (ATT). Methods This was retrospective single‐center study to analyze the safety and its outcomes undergoing while continuation phase ATT. Results Between 2013 2022, 30 underwent Median age 38 years 70% were males. Majority (86.7%) had extrapulmonary tuberculosis, most site involvement being tubercular lymphadenitis. 14/30...
Abstract Background Adenine phosphoribosyl transferase (APRT) deficiency is a rare genetic form of kidney stones and/or failure characterized by intratubular precipitation 2,8 dihydroxyadenine crystals. Early diagnosis and prompt management can completely reverse the injury. Case presentation 44 year old Indian male, renal transplant recipient got admitted with acute graft dysfunction. Graft biopsy showed light brown refractile crystals surrounding giant cell reaction, consistent APRT...
Introduction: Renal transplant recipients now have better graft survival rates, but continue to develop opportunistic infections. The present study was aimed at finding the incidence of infections in tropical environment live-related recipients. Materials and Methods: carried out retrospectively with help medical records a tertiary care hospital North India from 2006 2010. demographic details were noted, data analyzed for any possible risk factor. Results: A total 1270 patients studied,...
The association between thrombotic microangiopathy (TMA) and pancreatitis is well known. However, TMA leading to more common than the latter. renal failure are both poor prognostic markers in acute pancreatitis. TMA, if not managed timely, can lead severe morbidity mortality. We report a case of young boy whom decisive timely diagnosis management post helped complete patient recovery.
Membranous nephropathy is known to be associated with number of autoimmune diseases. Occurrence PLA2R positive membranous sjogren's syndrome and chronic inflammatory demyelinating neuropathy (CIDP) quite rare. Role antigen in diseases like CIDP largely unknown. Choice initiation immunosuppression if required may also governed by the presence other along nephropathy.
Respiratory tract infections are life-threatening in solid-organ transplant recipients that pose risk to the graft and patient. This study was undertaken examine clinical microbiological spectrum of pneumonia renal recipients.
Background Rabbit antithymocyte globulin (rATG) is frequently utilized as an induction therapy in kidney transplant recipients (KTRs). Full-dose rATG (7-10 mg/kg) has been associated with increased morbidity. However, definitive data on the appropriate dosage remains scarce. In this study, we evaluated efficacy and tolerability of varying doses KTRs. Methodology A single-center, retrospective, observational study was conducted between 2009 2014 a cohort 208 KTRs who received therapy....
Kidney disease is a rapidly growing non-communicable ailment, with Delhi-National Capital Territory (NCT) emerging as key hub for nephrology services in India. The field’s evolution Delhi-NCT has seen significant milestones, starting the establishment of department at AIIMS 1969 and expansion dialysis transplantation across region. Currently, hosts over 300 nephrologists more than 70 centers, serving 13,500 patients on hemodialysis around 550 peritoneal dialysis. region leads number kidney...
Rifampicin is one of the most effective anti-tuberculous therapy. an enzyme inducer and hence, in a post-renal transplant recipient, dose calcineurin inhibitors needs to be frequently monitored modulated accordingly. In resource-limited (low- middle-income countries) setting this not always feasible. So, we evaluated non-rifampicin based anti-tuberculosis therapy (ATT) using levofloxacin kidney recipients.